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Macrophages, central mediators of inflammation, obtain pro inflammatory (M1) and 
anti-inflammatory (M2) phenotypes, which can be modulated by soluble factors, 
including natural products. Despite the crucial protective role of inflammation, chronic 
or deregulated inflammation can lead to pathological states, such as autoimmune 
diseases, metabolic disorders, cardiovascular diseases and cancer. In the present study 
we evaluated in depth the anti-inflammatory activity of the brominated diterpene 
neorogioltriol and identified two structurally related diterpenes, neorogioldiol and 
O11,15-cyclo-14-bromo-14,15-dihydrorogiol-3,11-diol, with equally potent activity. We 
investigated the mechanism of action of the three metabolites and found that all three 
suppressed macrophage activation and promoted an M2-like anti-inflammatory 
phenotype by inducing expression of Arginase1, MRC1, IRAK-M, the transcription factor 
C/EBPβ and the miRNA miR-146a. In addition, they suppressed iNOS induction and 
nitric oxide production. Importantly, treatment of mice with the bioactive compounds 
suppressed DSS-induced colitis by reducing tissue damage and pro-inflammatory 
cytokine production. Thus, all these three diterpenes are promising lead molecules for 
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